Glutathione

Glutathione is a small molecule the human body makes naturally in every cell, built from three amino acids, that serves as the body’s primary internal antioxidant. It is sold as an oral supplement, an intravenous infusion at some clinics, and a topical or intranasal product for uses ranging from general “detox” and skin-lightening claims to experimental Parkinson’s disease research. Some forms have real, published human trials behind them; many popular claims and dosing figures circulating online do not.

Research snapshot

Peptide category	Naturally occurring tripeptide, treated on this site as a small-molecule compound (produced, sold, and studied as a metabolite/supplement rather than a designed signaling peptide)
Primary research interest	Antioxidant support; also marketed for “detox,” skin-lightening, and experimental Parkinson’s disease research
Highest available evidence	Mixed by use case — some forms (e.g. IV, intranasal in specific research contexts) have published human trials; many popular claims and dosing figures circulating online do not
Human research available	Yes for some forms/uses; not for others (varies by route and claimed use — see body of page)
Development status	Naturally occurring endogenous metabolite; not a novel or synthetic invention
Regulatory status	Not FDA-approved for skin lightening, anti-aging, or “detox” indications; oral form sold as an unregulated dietary supplement; IV form used off-label with some international regulatory cautions about unregulated whitening injections
Last reviewed	September 2026

Technical identity

Primary name	Glutathione (GSH)
Alternative names	L-Glutathione; reduced glutathione
Peptide sequence	Glu-Cys-Gly (gamma-glutamylcysteinylglycine — an atypical gamma-peptide linkage, not a standard alpha-peptide bond)
Amino-acid length	3 (tripeptide)
Molecular formula	C10H17N3O6S
Molecular weight	Approximately 307.32 g/mol
CAS Registry Number	70-18-8
PubChem CID	124886
Peptide class	Endogenous tripeptide antioxidant (treated as a small molecule on this site given its use pattern)
Primary biological target	Central cellular antioxidant/redox-buffering system; cofactor for glutathione peroxidase and related enzymes
Developer or originator	Naturally occurring; synthesized endogenously in every human cell
Development status	Not in pharmaceutical development as a novel drug; sold as a supplement and used off-label in clinical/cosmetic settings

What it is

Glutathione is a tripeptide, a molecule made of three linked amino acids: glutamate, cysteine, and glycine. Although it is technically a peptide by chemical structure, it is treated on this site as a small-molecule compound because that is how it is produced, sold, studied, and discussed in practice, as a naturally occurring metabolite and supplement rather than a designed signaling peptide. It is not a novel or synthetic invention; it was first characterized chemically in the early twentieth century and its central role in cellular antioxidant defense has been studied for decades.

Every cell in the human body produces glutathione internally using three enzymatic steps, and it exists in two interconvertible forms: the reduced, active form (GSH) and the oxidized form (GSSG), which is regenerated back to GSH by the enzyme glutathione reductase. The ratio of GSH to GSSG is commonly used in research as a marker of oxidative stress. Because levels of glutathione decline with age and with various diseases, and because it plays a central role in detoxifying reactive oxygen species and certain toxins in the liver, it has attracted interest as a supplement for general antioxidant support, skin lightening, liver health, and more speculatively, neurodegenerative disease.

Commercially, glutathione is sold in oral tablet and capsule form, as a liposomal or sublingual product intended to improve absorption, as an intravenous infusion offered at some medical and wellness clinics (particularly marketed for skin lightening in parts of Asia and elsewhere), and as an intranasal formulation that has been studied specifically in Parkinson’s disease research. It is not an approved drug for any of the “wellness” indications it is marketed for online; the IV and intranasal routes used in research and clinic settings differ meaningfully from oral supplement use in bioavailability and evidence base.

How does it work?

Plain-English explanation

Think of glutathione as the body’s primary internal “sponge” for mopping up damaging byproducts of normal metabolism, called reactive oxygen species or free radicals, before they can damage cells, proteins, and DNA. It also helps the liver process and remove certain toxins and drugs. Because oxidative stress is implicated in aging and many diseases, maintaining adequate glutathione levels is considered important for general cellular health, though that does not automatically mean that taking extra glutathione as a supplement will measurably raise levels inside cells or produce a health benefit.

Technical explanation

Glutathione (gamma-L-glutamyl-L-cysteinylglycine) neutralizes reactive oxygen and nitrogen species directly and serves as an essential cofactor for antioxidant enzymes including glutathione peroxidase and members of the glutaredoxin family, which couple GSH oxidation to the reduction of peroxides and other oxidizing species. It also plays a central role in phase II liver detoxification via glutathione S-transferase-mediated conjugation, and is a cofactor in the metabolism of acetaminophen (paracetamol) overdose, where N-acetylcysteine is given clinically to replenish the cysteine needed for glutathione synthesis. A key limitation for supplementation is that orally ingested glutathione is substantially broken down by intestinal peptidases (protein-digesting enzymes) before absorption, and cell membranes lack an efficient dedicated transporter for intact glutathione, meaning oral glutathione does not reliably or substantially raise intracellular glutathione levels the way researchers once assumed; this is why alternative approaches, including N-acetylcysteine, liposomal formulations, sublingual delivery, and intravenous or intranasal administration, are used or studied as ways to work around poor oral bioavailability.

Potential benefits and research applications

Skin lightening (melasma and hyperpigmentation)

What is being investigated: whether oral or topical glutathione can reduce skin pigmentation. How the effect might occur: glutathione is believed to shift melanin production toward a lighter pigment type (pheomelanin) and to inhibit tyrosinase, an enzyme involved in melanin synthesis. Evidence: several published randomized controlled trials in humans, including oral glutathione alone and in combination with other antioxidants, have reported modest reductions in skin pigmentation measures over several weeks to months. Strength: has been shown in multiple small-to-moderate human randomized trials, though results and study quality vary, and effect sizes are generally modest. Limitation: study populations, formulations, and combination ingredients vary considerably, and this is a cosmetic rather than medical application; the U.S. FDA has not approved glutathione for skin lightening.

Parkinson’s disease (intranasal route)

What is being investigated: whether intranasal glutathione can improve motor symptoms in Parkinson’s disease by reducing oxidative stress in the brain. How the effect might occur: Parkinson’s disease involves substantial oxidative damage in dopamine-producing neurons, and intranasal delivery is being explored as a way to bypass poor systemic absorption and the blood-brain barrier. Evidence: a Phase IIb randomized controlled trial funded in part by the Michael J. Fox Foundation studied intranasal glutathione in Parkinson’s patients. Strength: registered human clinical trial evidence exists for this specific route and population, which is a substantially higher evidence tier than most other glutathione claims, though results from Parkinson’s trials of this type have historically been mixed to modest. Limitation: this evidence applies specifically to the intranasal route in Parkinson’s patients and does not generalize to oral supplement use for general “brain health” or anti-aging claims.

General antioxidant and “anti-aging” support

What is being investigated: whether raising glutathione levels through supplementation supports general cellular health, immune function, and slows aging-related decline. How the effect might occur: by supplementing the body’s primary antioxidant defense system. Evidence: largely inferred from glutathione’s well-established biochemical role and from observational associations between lower glutathione levels and age or disease, rather than from trials showing that supplementation produces measurable health benefits in generally healthy people. Strength: is being investigated for and may support general antioxidant status in some studies measuring blood biomarkers, but broad anti-aging and immune claims have not been established in rigorous human outcome trials. Limitation: oral bioavailability concerns mean many oral products may not meaningfully raise intracellular glutathione at all, which undercuts much of the marketing built around this use.

Liver support and detoxification

What is being investigated: glutathione’s use, largely via IV administration, in supporting liver function in certain clinical and research contexts distinct from general wellness “detox” marketing. How the effect might occur: through its central role in phase II liver detoxification pathways. Evidence: the biochemical role is well established, and IV glutathione has been studied in specific clinical contexts (such as chemotherapy-related toxicity), but this differs substantially from the “detox” claims made for oral supplements sold to healthy consumers. Strength: mechanistically well-supported for the compound’s known biochemistry; the specific consumer “detox” marketing claim has not been established. Limitation: general wellness “detox” claims for oral glutathione supplements are not supported by dedicated human outcome trials in that population.

What dosage information circulates?

Figures in this section summarize amounts and schedules reported in published research or circulating online. Their inclusion documents what is reported and does not establish that a regimen is verified, safe, effective, or appropriate.

Amounts studied in human research

Published randomized controlled trials of oral glutathione for skin lightening have commonly used amounts in the range of approximately 250 to 500 milligrams per day, taken orally, sometimes combined with vitamin C, alpha-lipoic acid, or zinc, over study periods of roughly 4 to 12 weeks (evidence category: published human clinical trial, though sample sizes in these trials are generally small to moderate). The intranasal Parkinson’s disease trial used a specific intranasal glutathione formulation and dosing schedule distinct from oral products; exact intranasal dosing details are protocol-specific and are not interchangeable with oral milligram figures. IV glutathione doses used in clinic and limited research settings for skin-lightening or wellness purposes are not consistently reported in the peer-reviewed literature reviewed for this entry, and IV clinic protocols in commercial settings often are not backed by a published dosing trial at all.

Amounts studied in animal research

Not consistently reported. Because glutathione is an endogenous molecule already present in all animal cells and widely used as a laboratory reagent, dedicated animal dose-ranging studies specifically modeling human supplementation are not a major, distinct part of the literature in the way they are for novel synthetic peptides.

Practitioner and community-reported protocols

Wellness clinics and vendor websites describe oral glutathione doses ranging widely, commonly citing 500 to 1,000 milligrams per day or higher for general “antioxidant support” or skin-lightening use, and IV “glutathione push” or “glutathione drip” protocols at doses commonly cited online in the range of 600 to 2,000 milligrams per infusion, administered weekly to a few times per week at some clinics. These IV figures are widely repeated across wellness-clinic and vendor marketing pages but are not consistently traceable to a specific published clinical trial protocol for the IV route (evidence category: vendor/practitioner reported; origin unclear for most IV figures). Widely repeated online, but its original source could not be verified for the general “skin brightening IV drip” doses commonly advertised.

Side effects, risks, and limitations

Oral glutathione is generally reported as well tolerated in the clinical trials that have studied it, with mild gastrointestinal complaints occasionally reported. Intravenous glutathione, particularly at the higher doses and frequencies used in some commercial “whitening drip” clinics, carries additional risks associated with any IV infusion (injection site reactions, infection risk from improper administration) and has been associated in case reports with rare but serious adverse events, including severe skin reactions (Stevens-Johnson syndrome has been reported in isolated cases linked to IV glutathione use) and, importantly, IV glutathione for cosmetic skin-lightening is not FDA-approved and its use for this purpose in unregulated or poorly regulated clinic settings has drawn specific safety warnings in some countries. A mechanism-based theoretical concern with skin-lightening use is reduced natural photoprotection from melanin, though this has not been rigorously quantified in trials. Long-term safety of chronic high-dose oral or repeated IV glutathione supplementation in healthy people has not been well studied.

Regulatory and developmental status

Glutathione is not an FDA-approved drug for skin lightening, general anti-aging, or “detox” indications; oral glutathione is sold in the United States as an unregulated dietary supplement, meaning it is not required to demonstrate efficacy for any of these marketed uses before sale. Intravenous glutathione is used off-label in some clinical and cosmetic settings; it is not FDA-approved for cosmetic skin lightening, and some regulatory bodies internationally have issued specific cautions about unregulated IV glutathione whitening injections. Intranasal glutathione for Parkinson’s disease remains an investigational research formulation studied in clinical trials rather than an approved treatment. Date verified: 2026-09-20.

Frequently asked questions

What is glutathione?

Glutathione is a small molecule made of three amino acids that the body produces naturally in every cell as its primary internal antioxidant. It is also sold as an oral, IV, and intranasal supplement or clinical product.

How does glutathione work?

It directly neutralizes damaging reactive oxygen species and serves as a required cofactor for several antioxidant enzymes, and it plays a central role in the liver’s detoxification processes.

What dosage has been studied for skin lightening?

Published randomized trials of oral glutathione for skin lightening have commonly used roughly 250 to 500 milligrams per day over several weeks to a few months, often combined with other antioxidants.

What dosage information circulates online for IV “whitening drips”?

Wellness clinics commonly advertise IV doses in the range of 600 to 2,000 milligrams per infusion, administered weekly or more often, but these figures are widely repeated in marketing material without a clearly identifiable original clinical trial source.

Does oral glutathione actually raise levels inside cells?

This is uncertain and debated. Orally ingested glutathione is substantially broken down by digestive enzymes and cells lack an efficient transporter for the intact molecule, which is why some researchers question how much oral supplementation actually raises intracellular glutathione, despite this being the core assumption behind most oral product marketing.

Has glutathione been studied in humans?

Yes, more so than many longevity compounds. There are published randomized controlled human trials for oral glutathione in skin lightening and for intranasal glutathione in Parkinson’s disease, though evidence for general “anti-aging” or wellness claims is much thinner.

Is glutathione FDA-approved?

Not for skin lightening, detox, or anti-aging use. It is sold as an unregulated dietary supplement for oral use in the United States; the IV cosmetic use common at some clinics is off-label and not FDA-approved.

What remains unknown?

Whether oral supplementation meaningfully raises intracellular glutathione in most users, the long-term safety of chronic high-dose or repeated IV use, and whether any broad anti-aging or immune benefit exists beyond the specific skin-lightening and Parkinson’s disease research contexts that have actual trial data.

Bottom line

Glutathione is a well-characterized, naturally occurring antioxidant with a real (if narrower than marketing suggests) body of human clinical evidence: published randomized trials support modest effects on skin pigmentation from oral use, and a registered clinical trial has studied intranasal glutathione in Parkinson’s disease. Widely marketed uses for general anti-aging, immune support, and “detox,” along with many of the higher IV doses advertised at wellness clinics, are not backed by dedicated outcome trials at those specific doses, and oral bioavailability limitations remain a genuine scientific question mark for the entire oral-supplement category. No amount here should be read as a recommendation; dosage information is included to document what has been studied and what is marketed, not to establish a safe or effective regimen.